Safety profile of anakinra in the management of rheumatologic, metabolic and autoinflammatory disorders

Medicine and Dentistry

• Anakinra 100%
• Biological Product 60%
• Autoinflammatory Disease 60%
• Water-Electrolyte Imbalance 40%
• Infection 40%
• Tuberculosis 40%
• Drug 40%
• Chemotherapeutic Agent 40%
• Biological Response Modifier 40%
• Inflammatory Disorder 40%
• Inpatient 40%
• Diabetes Mellitus 20%
• Diseases 20%
• Serum 20%
• Rheumatoid Arthritis 20%
• Cell Type 20%
• Biological Activity 20%
• Development 20%
• Systemic Juvenile Idiopathic Arthritis 20%
• Adult Onset Still Disease 20%
• Corticosteroid 20%
• Interleukin 1 20%
• Mycobacterium Tuberculosis 20%
• Gout 20%
• Antirheumatic Agent 20%
• Schnitzler Syndrome 20%
• Synovial Fluid 20%
• Patient 20%
• Tissues 20%
• Clinician 20%

Immunology and Microbiology

• Anakinra 100%
• Biological Product 60%
• Autoinflammatory Syndromes 60%
• Mycobacterium Tuberculosis 60%
• Inflammatory Arthritis 20%
• Proinflammatory Cytokine 20%
• Interleukin 1 20%
• Biological Activity 20%
• Juvenile Idiopathic Arthritis 20%
• Gout 20%
• Synovial Fluid 20%
• Adult-Onset Still's Disease 20%
• Development 20%
• Cells 20%
• Tissues 20%
• Bear 20%